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Abstract
Background: The Regional Committee for Africa of the World Health Organization (WHO) in
2001 expressed concern that some health-related studies undertaken in the Region were not
subjected to any form of ethics review. In 2003, the study reported in this paper was conducted to
determine which Member country did not have a national research ethics committee (REC) with
a view to guiding the WHO Regional Office in developing practical strategies for supporting those
countries.
Methods: This is a descriptive study. The questionnaire was prepared and sent by diplomatic
pouch to all the 46 Member States in the WHO African Region, through the WHO country
representatives, for facilitation and follow up. The data were entered in Excel spreadsheet and
subsequently exported to STATA for analysis. A Chi-Squared test (χ2) for independence was
undertaken to test the relationship between presence/absence of Research Ethics Committee
(REC) and selected individual socioeconomic and health variables.
Results: The main findings were as follows: the response rate was 61% (28/46); 64% (18/28)
confirmed the existence of RECs; 36% (10/28) of the respondent countries did not have a REC
(although 80% of them reported that they had in place an ad hoc ethical review mechanism); 85%
(22/26) of the countries that responded to this question indicated that ethical approval of research
proposals was, in principle, required; and although 59% of the countries that had a REC expected
it to meet every month, only 44% of them reported that the REC actually met on a monthly basis.
In the Chi-Squared test, only the average population in the group of countries with a REC was
statistically different (at 5% level of significance) from that of the group of countries without a REC.
Conclusion:  In the current era of globalized biomedical research, good ethics stewardship
demands that every country, irrespective of its level of economic development, should have in place
a functional research ethics review system in order to protect the dignity, integrity and safety of its
citizens who participate in research.
Background
"Regrettably, (over) 50 years after the Nuremberg trials and
the Nuremberg code, unethical (bio)medical research on
humans continues, even in highly privileged countries" [1]
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Biomedical research involves research on pharmaceuti-
cals, medical devices, medical radiation and imaging, sur-
gical procedures, medical records and biomedical
samples, as well as epidemiological, social, and psycho-
logical investigations [2]. It often entails collection, anal-
ysis, and interpretation of information obtained from
human beings. Research must be undertaken in an ethical
manner so that it assures protection of the dignity, integ-
rity, and safety of all actual or potential research partici-
pants [3].
A recent revelation that about 25% of health-related stud-
ies in developing countries were not subjected to some
form of ethics review by an international review board,
national ethics board, or ministry/department of health is
worrisome [4]. A similar concern was expressed by the
Regional Committee for Africa of the World Health
Organization (WHO) in 2001.
Since the end of World War II, ethical and scientific stand-
ards for conducting biomedical research on human sub-
jects have been enshrined in international guidelines,
including the Nuremberg Code [5], the Declaration of
Geneva [6], the International Covenant on Civil and
Political Rights [7], the International Code of Medical
Ethics of the World Medical Association [8], the Declara-
tion of Helsinki [9], the CIOMS International Ethical
Guidelines for Biomedical Research Involving Human
Subjects [3], the WHO Operational Guidelines for Ethics
Committees that Review Biomedical Research [2] and the
ICH Guidelines for Good Clinical Practice [10].
Although there is variance in the scope and emphasis of
the above-mentioned international instruments on the
ethics of medical research, they all require ethical justifica-
tion and scientific validity of research; ethical review;
informed consent; vulnerability of individuals, groups,
communities and populations; women as research sub-
jects; equity regarding burdens and benefits; choice of
control in clinical trials; confidentiality; compensation for
injury; strengthening of national or local capacity for eth-
ical review; and obligations of sponsors to provide health
care [3].
The growing volume of collaborative biomedical studies
involving national, multinational and transnational part-
ners developing various interventions targeted against
health conditions such as HIV/AIDS, malaria, tuberculo-
sis, childhood illnesses, and causes of maternal morbidity
and mortality contained in the Millennium Development
Goals, and the potential for exploitation in such research,
make it essential for every country to have a functional
Research Ethics Committee (REC). The purpose of
national REC is to contribute independently, compe-
tently, and efficiently to safeguard the dignity, rights,
safety, and well-being of all actual or potential research
participants; and ensuring the highest attainable quality
in the science and ethics of biomedical research [2] in the
country.
The aim of the study reported here was to ascertain which
Member State in the WHO African Region had a national
bioethics committee and which did not (as at 2003), in
order to guide the Organization in its support to the estab-
lishment of RECs, as well as their strengthening wherever
they existed.
Methods
The questionnaire was deliberately kept short and simple
in order to ensure quick response. It consisted of ques-
tions aimed at obtaining the following information: exist-
ence of a national ethics committee dealing with health
issues; its composition and main functions; frequency of
scheduled meetings and number of times the committee
actually met last year; if a REC did not exist, were there
mechanisms for clearing ethical issues in research; and
whether a national ethical approval was required for
implementation of research proposals.
The questionnaire was developed in French and subse-
quently translated into English and Portuguese. Of the 46
Member countries in the WHO African Region, 21 speak
French, 20 English and 5 Portuguese. It was sent by WHO
diplomatic pouch to each of the 46 countries through the
WHO country representatives for facilitation and follow
up. The data were entered in Excel spreadsheet and subse-
quently exported to STATA for analysis.
A Chi-Squared test (χ2) for independence was undertaken
to test the relationship between presence/absence of
Research Ethics Committee (REC) and selected individual
socioeconomic and health variables. The null hypothesis
(H0) is that there is no difference between the mean of a
given socioeconomic or health variable among the group
of countries with REC and the group without REC. The
alternative hypothesis (HA) is that there is difference
between the mean of a given socioeconomic or health var-
iable among the group of countries with REC and the
group without REC. Thus, for maternal mortality per
100000 live births, the hypotheses are as follows: (i) H0:
There is no difference in average maternal mortality ratio
between the group of countries with REC and those with-
out; and (ii) HA: There is difference in average maternal
mortality ratio between the group of countries with REC
and those without. If the computed Chi-square ( ) is
greater than critical Chi-square ( ), then we reject the
null hypothesis and accept the alternative hypothesis at a
given level of significance, e.g. 95% confidence level or
5% level of significance. On the other hand, if the com-
puted Chi-square ( ) is less than critical Chi-square
χC
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( ), then we accept the null hypothesis, i.e. there is no
reasonable evidence to reject the H0.
The data on maternal mortality per 100000 live births,
population in a country, life expectancy at birth, probabil-
ity of dying (per 1000) below age 5 years, probability of
dying (per 1000) between age 15–60 years and infant
mortality per 1000 live births were obtained from the
World Health Report 2005 [19]. While the data on gross
national income per capita (US$), percentage of popula-
tion aged 15 years and above that is illiterate, and gross
primary enrolment (% of school age population) were
taken from the World Bank website [20].
Results
A total of 28 (60.9%) of the 46 countries completed the
questionnaire and returned it to the investigators.
Response rates of 50% (10/20), 67% (14/21) and 80%
(4/5) were recorded for the English, French and Portu-
guese speaking countries respectively. An average of three
remainders were sent through WHO Country Representa-
tives to non-responding countries.
Of the 28 countries that responded, 64% (18/28) con-
firmed the existence of a national REC dealing with
bioethics research issues (Table 1). This meant that 36%
(10/28) of the respondent countries did not have an eth-
ics committee. Sixty-seven per cent (12/18) of the coun-
tries that did have an ethics committee had it named as
national bioethics committee; the remaining 33% (6/18)
had alternative names for their national entity that per-
formed the functions of REC.
As indicated in Table 2, the reported composition of REC
membership varied widely. Over 50% of the countries
had specialists from national medical research council/
institute, universities and social sciences, and public
health professionals from ministry of health.
The number of members on the national committee
ranged from 4 to 37. The average membership was 11,
with a standard deviation of 8.
The countries that confirmed the existence of a REC were
requested to name its main functions. Their responses are
summarized in Table 3. All these countries (18/18) indi-
cated 'Review and approve all research protocols on
human subjects' as one of the main functions of REC.
Eighty per cent (8/10) of the countries that did not have a
REC reported that they had ad hoc mechanisms for ethical
review of bioethics research protocols. These consisted of
mainly hand-picking a few colleagues at the ministry of
health to review proposals whenever they were submitted.
The countries were asked whether REC was supposed to
meet monthly, quarterly, twice a year, once a year, or on
demand. Seventeen countries responded to this question;
of them, ten indicated the frequency as monthly, three
quarterly, one twice a year, and three on demand.
Table 1: Presence/absence of RECs
Country Presence of REC
Algeria Yes
Angola Yes
Botswana Yes
Burkina Faso Yes
Cameroon Yes
Cape Verde No
Chad No
Congo No
Democratic Republic of Congo Yes
Ethiopia Yes
Gambia Yes
Guinea Yes
Guinea Bissau No
Guinea Equatorial No
Kenya Yes
Malawi No
Mali Yes
Mauritania No
Mauritius Yes
Mozambique Yes
Niger Yes
Rwanda Yes
Sao Tome et Principe No
Seychelles Yes
Swaziland No
Togo No
Zambia Yes
Zimbabwe Yes
Source: Survey data
χκ
2
Table 2: Composition of research ethics committees in countries 
that reported their existence
Cadre Percentage 
(Frequency)
National medical research institute/council 72% (13/18)
University 61% (11/18)
National medical association 44% (8/18)
Renowned researcher 33% (6/18)
Social scientist 50% (9/18)
Public health professional from ministry of health 89% (16/18)
National bureau of standards 11% (2/18)
WHO 5% (1/18)
Attorney-general 39% (7/18)
Others 83% (15/18)BMC Medical Ethics 2005, 6:10 http://www.biomedcentral.com/1472-6939/6/10
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The countries were also requested to indicate the actual
frequency of REC meetings during the last year. A total of
16 countries responded to this question; of them, seven
reported as monthly, five quarterly, three twice a year,
zero annually, and one indicated that their REC had never
met.
Lastly, all countries were asked whether ethical approval
for research proposals was actually required. Eighty-five
per cent (22/26) of the countries that responded to this
question indicated that an approval was required.
Table 4 presents the Kruskal-Wallis test of equality of pop-
ulations means of socio-economic and health variables.
This test was undertaken to test the relationship between
presence/absence of REC and the individual socio-eco-
nomic and variables. The p value reported in the third col-
umn of Table 4 is the estimated probability of rejecting
the null hypothesis (H0) when the hypothesis is true. The
computed Chi-squared value of the population variable
was greater than the critical Chi-squared value; thus we
can conclude that the average population in the group of
countries with a REC was statistically different from that
of the group of countries without a REC. On the other
hand, since the computed values for all the other socio-
economic and health variables were less than their
respective critical Chi-squared values (at 5% level of sig-
nificance) we accept the H0.
Discussion
Key findings
The purpose of this study was to ascertain which country
in the WHO African Region had a national bioethics com-
mittee and which did not. The key findings were as fol-
lows: (i) the response rate was 61% (28/46); (ii) 64% (18/
28) confirmed the existence of a national ethics
committee; (iii) 36% (10/28) of the respondent countries
did not have an ethics committee (although 80% of them
reported that they used an ad hoc ethical review mecha-
nism); (iv) 85% (22/26) of the countries that responded
to this question indicated that ethical approval of research
proposals was, in principle, required; and (v) although
59% of the countries expected their REC to meet every
month, only 44% reported that it actually met on a
monthly basis.
Implications
Response rate
It is very sad that only 28 out of 46 countries responded to
the questionnaire. It would have been preferable to have
responses from all the 46 countries. This would have pro-
vided WHO and the Special Programme for Research and
Training in Tropical Diseases Research (TDR) with a
strong basis for planning support to the countries in the
African Region that needed it to develop or strengthen
their ethical review systems.
Thus, the analysis reported in this paper was confined to
the 28 countries that responded and mainly to the 18 who
reported to have had a REC. We are not certain why 18
countries did not respond to the questionnaire. However,
it could partly be attributed to lack of a culture for gener-
ating and utilizing evidence in decision-making in the
Region.
Existence of REC
Although from this study we cannot assess the functional
status of RECs in the 18 countries that reported their exist-
ence, we are more concerned about the remaining ten
countries that did not have a national ethics committee in
an era in which biomedical research (and science in gen-
eral) has become increasingly globalized. This is quite dis-
concerting in a Region where 39% of the adult population
is illiterate and 44% live below the international poverty
line of US$1 per day [11]. They thus are largely unaware
of their basic human rights, including the right to refuse
to participate in health research. In the absence of any
checks and balances due to lack of functional RECs, the
populations in these countries run the risk of being
abused by unscrupulous researchers [1,2,12].
WHO is currently supporting Member countries without
RECs to establish them and those with RECs to improve
their performance. Given the critical importance of RECs,
we do hope that the ongoing support to countries in the
African Region would be accelerated and sustained.
Functions/roles of REC
The roles of ethical review committees are to: ensure that
all proposed interventions (drugs, vaccines, medical
devices or procedures) are safe; ensure that proposed
research is scientifically sound; ensure that all other ethi-
cal concerns arising from a protocol are satisfactorily
Table 3: Main functions of research ethics committees in 
countries that reported their existence
Functions Percentage 
(Frequency)
Review and approve all research protocols on 
human subjects
100% (18/18)
Ensure that projects sponsored by external 
donors are submitted for approval to ethical 
clearance committee of the initiating country
5% (1/18)
Build the capacity of institutional and regional 
ethical clearance committees
11% (2/18)
Give clearance for export of samples or 
specimens for research related to human health
5% (1/18)
Coordinating and promoting research 22% (4/18)BMC Medical Ethics 2005, 6:10 http://www.biomedcentral.com/1472-6939/6/10
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resolved both in principle and in practice; and ensure
competence of investigators; keep records of decisions;
monitor and audit the conduct of ongoing research
projects [3]; "... evaluate research proposals with special
attention to risk/benefit ratios, equity in distribution of
benefits and burdens, potential conflicts of interests, the
adequacy of information provided for subjects, and the
protection of freedom: within the consent process; enable
study subjects to withdraw without prejudice to care; and
persuade investigators to publish, to educate and assist
faculty, researchers and community in understanding and
appreciating the ethics of research" [1].
It was beyond the scope of the current study to assess the
extent to which RECs in the Region performed the above-
mentioned roles. However, it appeared that all the
respondent countries regarded the main function of REC
to be to review and approve research protocols on human
subjects. There was no mention during the survey that
RECs were expected to also monitor the actual conduct of
research to ensure justice in the distribution of costs and
benefits. We concur with Benatar [1] that "lack of atten-
tion to how research is actually being conducted is a seri-
ous shortcoming, requiring critical attention in an era of
expanding research, growing links with industry and com-
mercial organizations, documented inadequacies in the
protection of research subjects and with growing recogni-
tion of the need to avoid exploitation." In short, it is
vitally important for RECs to ensure that they competently
implement all the guidelines stipulated by the Council for
International Organizations of Medical Sciences (CIOMS)
[3].
Composition of REC
The CIOMS guidelines [3] recommend that the member-
ship of REC "... should include physicians, scientists and
other professionals such as nurses, lawyers, ethicists and
clergy as well as lay persons qualified to represent the cul-
tural and moral values of the community." The survey
undertaken in the current study did not reveal the involve-
ment of nurses, ethicists and qualified laypersons in the
work of RECs. Since nurses constitute the largest group of
health personnel in health systems delivery and play a
critical role as members of the health team, it is vitally
important that they are involved in all ethical review proc-
esses. Also, non-inclusion of qualified laypersons in RECs
may compromise cultural and moral values [1].
Ethical approval
About 15% of the respondent countries indicated that
ethical approval of research proposals was not required.
In such countries, the health and safety of persons partic-
ipating in research was not assured. Even among the coun-
tries that indicated that ethical approval of research
proposals was, in principle, required, we were not able to
determine: (i) what proportion of research protocols were
actually approved before implementation; and (ii) what
proportion of the approved studies were actually moni-
tored by REC throughout the research project cycle, i.e.
protocol design, data collection and archival, data analy-
sis, dissemination of results, etc.
Frequency of REC meetings
In the current study, the frequency of REC meetings was
used both as an indicator of their functionality and as an
indirect proxy of performance. Half of the countries that
responded to this issue reported that their RECs met either
quarterly (31%) or twice a year (19%). In our view, the 3
to 6-month interval for REC meetings was too long as this
may result in unnecessary delays in processing (approval
or rejection) of research protocols. Where the sponsors of
research projects have stringent deadlines, such delays
may: (i) lead to withdrawal of research funding; (ii)
reduce the probability of researchers from concerned
countries getting funding in the future; (iii) increase the
cost of research; (iv) hamper the development and availa-
bility of public health interventions; and (v) provide
adverse incentives for some researchers to undertake
research covertly, without ethical review, especially in set-
Table 4: Kruskal-Wallis pairwise comparisons between variables of the group of countries with a research ethics committee and the 
group without
Variables Chi-squared statistic p-value Decision at 5% significance level
Maternal mortality per 100000 live births 0.026144 P = 0.8712 not significant, accept H0
Population in a country 7.468966 P = 0.0063 Significant, reject H0
Life expectancy at birth 0.7468966 P = 0.3876 not significant, accept H0
Probability of dying (per 1000) below age 5 years 0.331125 P = 0.565 not significant, accept H0
Probability of dying (per 1000) between age 15–60 years 0.186207 P = 0.6661 not significant, accept H0
Gross national income per capita (US$) 0.111875 P = 0.738 not significant, accept H0
Infant mortality per 1000 live births 0.028161 P = 0.8667 not significant, accept H0
Percentage of population aged 15+ years that is illiterate 0.22623 P = 0.6343 not significant, accept H0
Gross primary enrolment (% of school age population) 2.712306 P = 0.0996 not significant, accept H0
Note: Total number of observations = 28.BMC Medical Ethics 2005, 6:10 http://www.biomedcentral.com/1472-6939/6/10
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tings where appropriate legislations either do not exist or
are not policed.
One of the countries indicated that its REC had never met.
On hindsight, we feel we should have included questions
to probe the reasons for not holding REC meetings. At the
moment, it is not possible to know whether the absence
of meetings was due to lack of protocols to review, lack of
resources to organize the meetings, lack of quorum,
incompetent leadership, or due to some other logistical
reasons.
Agenda for action
The following actions need to be taken by countries in the
African Region:
• Countries should adapt appropriately international
guidelines for biomedical research involving human sub-
jects and make them available to all national health and
health-related research institutions and health facilities.
• As a good national ethics steward, every country should
ensure that it has an operational bioethics research review
system in place, which includes national, regional, district
and institutional (health facility) ethics committees.
• All countries should make sure that there are appropri-
ate policies and legislations to guide and reinforce
national bioethics research review systems.
• All countries should ensure that the composition and
mandates of RECs concur with international standards,
while providing institutional and financial resources to
ensure independent and competent execution of all their
roles. In this regard, we agree with Benatar [1] that all
countries should 'develop the expertise and infrastructure
required to (i) evaluate ethical problems; and (ii) educate
practitioners and researchers and facilitate development
of policy'.
• Each country should champion 'institutionalization of
training in ethics and human rights in relation to health at
all stages of the education and training of all health work-
ers, including medical, public health and nursing schools'
[13].
• All countries with RECs should develop mechanisms for
monitoring and auditing their work to ensure that they are
guaranteeing research adherence to all the CIOMS guide-
lines [3].
Further research
Our suggestions for further research in countries in the
African Region are as follows:
Situation analysis
A detailed survey and evaluation should be undertaken of
the effectiveness and efficiency of the entire national eth-
ics review system (including regional, district, institu-
tional and community-based RECs) in implementing the
CIOMS guidelines [3]. The evaluation can be accom-
plished using the WHO Guidelines [14]. It would be
important to evaluate: (i) the organization, financing and
functionality of the whole ethics review system; (ii) the
extent to which RECs are involved in monitoring every
stage/step in a research project cycle, including protocol
design, implementation, archival of data, analysis and
public dissemination of results; (iii) the effects of recent
information and technology developments on RECs'
modus operandi; and (iv) challenges faced by RECs.
Best practices
A detailed study and documentation of best-performing
research ethical review systems (including RECs) in the
Region should be conducted with a view to drawing les-
sons that other countries can emulate.
Principal-agency relationship
The principal-agency relationship between ethics commit-
tees and human research subjects should be established.
Institutionalisation of ethics education and training
A review of the existing international ethics review guide-
lines should be undertaken with a view to designing
appropriate undergraduate and postgraduate curricula on
research ethics. We concur with Fischer and Zigmund [15]
that research ethics should be taught throughout the grad-
uate curriculum. However, in addition, we are of the opin-
ion that in Africa where a majority of the health and allied
sciences undergraduates do not proceed to postgraduate
studies, it is critically important to introduce undergradu-
ates also to research ethics. After obtaining their degrees,
most undergraduates are normally deployed in rural areas
where, by virtue of being the most educated, they often
bear the burden of assuring that human rights of their
actual and potential clients are respected and protected in
the course of their clinical work and research carried out
by others.
Ways of improving REC performance
There is need for studies that explore the cost and benefits
(effectiveness) of alternative ways of leveraging the recent
advances in technology (teleconferencing, video confer-
encing, e-mail) to boost the work of RECs. Where these
technologies exist, they would not only reduce the cost of
face-to-face meetings but will also ensure timely review of
research protocols.BMC Medical Ethics 2005, 6:10 http://www.biomedcentral.com/1472-6939/6/10
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Partnerships
An exploration of the modalities of South-South and
North-South cooperation to strengthen the capacities of
bioethics review systems in the Region should be made.
For example, the WHO Regional Committee for Africa
[16] identified the need for effective inter-country mecha-
nisms to monitor health research in order to ensure that
existing national and international bioethics guidelines
were adhered to. In addition, countries with limited
bioethics capacities could easily tap into the internation-
ally available bioethics expertise through the Internet. We
are encouraged by the emphasis laid on capacity-building
for national ethics committees by the European and
Developing Countries Clinical Trials Partnership
(EDCTP).
Financing of REC work
Currently, the effectiveness of RECs in many countries is
greatly constrained by lack of resources [17]. Thus, there is
urgent need for research into finding innovative mecha-
nisms for ethically financing REC activities.
Conclusion
In the current era of globalized research, good ethics stew-
ardship demands that every country, whatever its level of
economic development, should have a functional
research ethics review system for protecting the dignity,
integrity and health safety of all its citizens participating in
research. Those countries that do not currently have such
systems should urgently leverage the services provided by
the WHO Strategic Initiative for Developing Capacity in
Ethical Review (SIDCER) [18] to develop capacities for
ensuring ethical research practices.
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